Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 1.01, 5.02, 7.01, 9.01 · 8-K

Capstone Companies, Inc.

CAPCOTCEQUITYCurrent

Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 23, 2025, the Company issued a press release announcing the appointment of Brian Rosen as a director. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.…

Filed Jan 23, 2025Accepted Jan 23, 2025, 3:30 AM ESTCIK 814926Accession 0001903596-25-000050
Share

Company context

Capstone has been engaged since 2017 in seeking to commercially exploit niche business lines or product lines that have growth and profit potential. Transitioning out of consumer product industry since 2024, the corporate mission has been to develop a business line with growth and profit potential that can, if successful, best serve the interests of Capstone’s public shareholders.

Current securities

Recent company filings

  1. 10-Q filingAug 13, 2026
  2. Entry into a Material Definitive AgreementAug 5, 2026
  3. Entry into a Material Definitive AgreementJul 8, 2026
  4. Entry into a Material Definitive Agreement · Regulation FD DisclosureMay 20, 2026
  5. Entry into a Material Definitive AgreementMay 15, 2026

Disclosure sections

Items 1.01, 5.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 23, 2025, the Company issued a press release announcing the appointment of Brian Rosen as a director. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K. As provided in General Instruction B.2 to Form 8-K, the information furnished in this Item 7.01 and in Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and such information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) ex99_1.htm

EX-99.1 2 ex99_1.htm Exhibit 99.1 FOR IMMEDIATE RELEASE January 23, 2025 BRIAN ROSEN, COMMERCIAL STRATEGY SENIOR EXECUTIVE, APPOINTED AS DIRECTOR OF CAPSTONE COMPANIES, INC. Deerfield Beach, FL (Business Wire) - Capstone Companies, Inc. (OTCQB: CAPC) announced today the appointment of Brian Rosen as a non-employee director, effective January 20, 2025. Mr. Rosen has extensive experience in marketing, business development, contract negotiation and government relations as well as experience as a member of two public companies’ management. He served as Senior Vice President, Global Market Access, Public Policy & Alliances (2021 - 2023), Senior Vice President, Commercial Strategy (2018 - 2021) and Vice President, Market Access, Policy, & Government Affairs (2015 - 2017) with Novavax, Inc. (NASDAQ: NVAX). Before Novavax, Inc., Mr. Rosen served as Chief Policy, Advocacy & Patient Services Officer (2014 - 2015), Senior Vice President, Public Policy (2013 - 2014) and Vice President, Legislative and Regulatory Affairs (2012 - 2013) for the Leukemia & Lymphoma Society, Washington, D.C. He also has a J.D. degree from Hofstra University School of Law. “Brian is skilled at pursuing new…

Open exhibit ↗